Older adults who get Pfizer, Moderna jab 94% less likely to be hospitalised for Covid-19 – study

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
loading...
Loading, please wait...
0:00
play article
Subscribers can listen to this article
The injection Lebelwane received would have been either the ChAdOx1 nCoV-19 vaccine or a placebo of normal salt water. The vaccine’s name stems from ChAdOx1, the virus it is made of, a weakened and non-replicating version of a common cold virus. Picture: iStock/ Pcess609
The injection Lebelwane received would have been either the ChAdOx1 nCoV-19 vaccine or a placebo of normal salt water. The vaccine’s name stems from ChAdOx1, the virus it is made of, a weakened and non-replicating version of a common cold virus. Picture: iStock/ Pcess609

Seniors who were fully vaccinated with the Pfizer or Moderna Covid-19 vaccines were found to be highly protected against hospitalisation compared to unvaccinated adults of the same age, the latest data reveals.

This week, the Centers for Disease Control and Prevention (CDC) released the small study, which involved 417 patients aged 65 or older.

While the vaccine showed 94% effectiveness against Covid-29-related hospitalisation, this dropped to 64% in participants who only received a single dose less than two weeks earlier.

Read this for free
Get 14 days free to read all our investigative and in-depth journalism. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed.
Subscribe
Already a subscriber? Sign in
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
27% - 9953 votes
No
73% - 26301 votes
Vote